Substandard, falsified and unregistered medicines in Latin America, 2017-2018 [PDF]
Objective. To assess all the incidents of substandard, falsified and unregistered medicines in 2017 and 2018 in Latin America, determining the types of products affected, stages of the supply chain in which incidents were detected, quality deviations ...
Robin Rojas-Cortés
doaj +3 more sources
Current scenario of spurious and substandard medicines in India: a systematic review. [PDF]
Globally, every country is the victim of substandard or spurious drugs, which result in life threatening issues, financial loss of consumer and manufacturer and loss in trust on health system. The aim of this enumerative review was to probe the extent on poor quality drugs with their consequences on public health and the preventive measures taken by ...
Khan AN, Khar RK.
europepmc +4 more sources
Substandard and falsified medicine screening technologies [PDF]
Substandard and falsified medicine screening technologies are invaluable tools for post-marketing surveillance of medicine quality, particularly in low- and middle-income countries.
Lukas Roth +2 more
doaj +2 more sources
Is this pill safe? Substandard medicines, mistaken solutions. [PDF]
In most developing countries you can buy prescription medicines from street vendors and in corner stores, with no need for a doctor’s note and with only the untutored vendor’s suggestions as to dosage and side effects. You might well wonder about safety.
Fried M.
europepmc +4 more sources
Medicine quality assessment in Nepal using semi randomised sampling and evaluation of a small scale dissolution test and portable Raman spectrometers [PDF]
Substandard and falsified medicines threaten global health and require reliable data and screening technologies to combat their spread. This study examined the quality of 241 samples containing azithromycin, cefixime, esomeprazole and losartan collected ...
Robin Schreiber +6 more
doaj +2 more sources
Substandard and falsified (SF) medicines have emerged as a global public health issue within the last two decades especially in low- and middle-income countries (LMICs). Serious consequences of this problem include a loss of trust and increased financial
Ulrike Holzgrabe, Holzgrabe Ulrike
exaly +3 more sources
A systematic review of counterfeit and substandard medicines in field quality surveys
Abdulaziz Fahad Abdulaziz Alghannam, Zoe Aslanpour, Sara Evans, Fabrizio Schifano Department of Pharmacy, University of Hertfordshire, Hatfield, Hertfordshire, United Kingdom Objectives: Counterfeit and substandard medicines pose a great threat to ...
Fabrizio Schifano
exaly +2 more sources
Combatting substandard and falsified medicines: a view from Rwanda.
Agnes Binagwaho and colleagues describe Rwanda's experience of pharmacovigilance for malaria and tuberculosis, and call for a global treaty and leadership by the World Health Organization to address the global manufacture and trade in substandard and falsified medicines.
Agnes Binagwaho +10 more
doaj +5 more sources
Substandard and falsified medicine recalls in the legitimate supply chain: a systematic review of evidence [PDF]
Objectives To compare international substandard and falsified (SF) medicine recall trends from published research papers based on governmental databases, summarise the extent of the problem in the legitimate supply chain, and identify ways to manage the ...
Bernard D Naughton, Izabella Fryze
doaj +2 more sources
Substandard medicines in resource‐poor settings: a problem that can no longer be ignored
SummaryThe circulation of substandard medicines in the developing world is a serious clinical and public health concern. Problems include under or over concentration of ingredients, contamination, poor quality ingredients, poor stability and inadequate packaging. There are multiple causes.
J-M, Caudron +5 more
exaly +4 more sources

